This company listing is no longer active
Salud financiera de hoja de balance de Acerus Pharmaceuticals
Salud financiera controles de criterios 0/6
Información clave
-329.8%
Ratio deuda-patrimonio
US$45.82m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$3.02m |
| Patrimonio | -US$13.89m |
| Total pasivo | US$61.57m |
| Activos totales | US$47.67m |
Actualizaciones recientes sobre salud financiera
Recent updates
Auditors Have Doubts About Acerus Pharmaceuticals (TSE:ASP)
Mar 14
Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?
Mar 12Acerus Pharmaceuticals' (TSE:ASP) Shareholders Are Down 88% On Their Shares
Jan 22The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares
Nov 30
Análisis de la situación financiera
Pasivos a corto plazo: ASP has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Pasivo a largo plazo: ASP has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: ASP has negative shareholder equity, which is a more serious situation than a high debt level.
Reducción de la deuda: ASP's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: ASP has less than a year of cash runway based on its current free cash flow.
Pronóstico de cash runway: ASP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 45.6% each year